92 related articles for article (PubMed ID: 20564346)
21. The influence of interstitial collagenase-1 genotype polymorphism on colorectal cancer risk in Iranian population.
Kouhkan F; Motovali-Bashi M; Hojati Z
Cancer Invest; 2008 Oct; 26(8):836-42. PubMed ID: 18798060
[TBL] [Abstract][Full Text] [Related]
22. Effect of COX2 -765G>C and c.3618A>G polymorphisms on the risk and survival of sporadic colorectal cancer.
Iglesias D; Nejda N; Azcoita MM; Schwartz S; González-Aguilera JJ; Fernández-Peralta AM
Cancer Causes Control; 2009 Oct; 20(8):1421-9. PubMed ID: 19468846
[TBL] [Abstract][Full Text] [Related]
23. Epigenetic inactivation of ID4 in colorectal carcinomas correlates with poor differentiation and unfavorable prognosis.
Umetani N; Takeuchi H; Fujimoto A; Shinozaki M; Bilchik AJ; Hoon DS
Clin Cancer Res; 2004 Nov; 10(22):7475-83. PubMed ID: 15569977
[TBL] [Abstract][Full Text] [Related]
24. Decreased expression of the RAS-GTPase activating protein RASAL1 is associated with colorectal tumor progression.
Ohta M; Seto M; Ijichi H; Miyabayashi K; Kudo Y; Mohri D; Asaoka Y; Tada M; Tanaka Y; Ikenoue T; Kanai F; Kawabe T; Omata M
Gastroenterology; 2009 Jan; 136(1):206-16. PubMed ID: 18992247
[TBL] [Abstract][Full Text] [Related]
25. c-MET expression level in primary colon cancer: a predictor of tumor invasion and lymph node metastases.
Takeuchi H; Bilchik A; Saha S; Turner R; Wiese D; Tanaka M; Kuo C; Wang HJ; Hoon DS
Clin Cancer Res; 2003 Apr; 9(4):1480-8. PubMed ID: 12684423
[TBL] [Abstract][Full Text] [Related]
26. MHC Class II alleles in ulcerative colitis-associated colorectal cancer.
Garrity-Park MM; Loftus EV; Sandborn WJ; Bryant SC; Smyrk TC
Gut; 2009 Sep; 58(9):1226-33. PubMed ID: 19251712
[TBL] [Abstract][Full Text] [Related]
27. The association of interleukin-16 polymorphisms with IL-16 serum levels and risk of colorectal and gastric cancer.
Gao LB; Rao L; Wang YY; Liang WB; Li C; Xue H; Zhou B; Sun H; Li Y; Lv ML; Du XJ; Zhang L
Carcinogenesis; 2009 Feb; 30(2):295-9. PubMed ID: 19073878
[TBL] [Abstract][Full Text] [Related]
28. [Association of TP53 gene polymorphisms with genetic susceptibility to liver metastases of colorectal cancer].
Wang AZ; Zhu ZZ; Cong WM
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Apr; 25(2):168-71. PubMed ID: 18393238
[TBL] [Abstract][Full Text] [Related]
29. Expression of annexin a5 is associated with higher tumor stage and poor prognosis in colorectal adenocarcinomas.
Xue G; Hao LQ; Ding FX; Mei Q; Huang JJ; Fu CG; Yan HL; Sun SH
J Clin Gastroenterol; 2009 Oct; 43(9):831-7. PubMed ID: 19461527
[TBL] [Abstract][Full Text] [Related]
30. GG genotype of cyclin D1 G870A polymorphism is associated with increased risk and advanced colorectal cancer in patients in Singapore.
Hong Y; Eu KW; Seow-Choen F; Fook-Chong S; Cheah PY
Eur J Cancer; 2005 May; 41(7):1037-44. PubMed ID: 15862753
[TBL] [Abstract][Full Text] [Related]
31. [Association between vascular endothelial growth factor gene 936 T/C polymorphism and colorectal cancer together with anastomotic leakage].
Wu GY; Wang XM; Keese M; Hasenberg T; Sturm JW
Zhonghua Wai Ke Za Zhi; 2006 Nov; 44(21):1505-7. PubMed ID: 17349182
[TBL] [Abstract][Full Text] [Related]
32. E-selectin gene S128R polymorphism is associated with poor prognosis in patients with stage II or III colorectal cancer.
Hebbar M; Adenis A; Révillion F; Duhamel A; Romano O; Truant S; Libersa C; Giraud C; Triboulet JP; Pruvot FR; Peyrat JP
Eur J Cancer; 2009 Jul; 45(10):1871-6. PubMed ID: 19361981
[TBL] [Abstract][Full Text] [Related]
33. High prevalence of fatty acid synthase expression in colorectal cancers in Middle Eastern patients and its potential role as a therapeutic target.
Uddin S; Hussain AR; Ahmed M; Abubaker J; Al-Sanea N; Abduljabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Bavi P; Al-Kuraya KS
Am J Gastroenterol; 2009 Jul; 104(7):1790-801. PubMed ID: 19491830
[TBL] [Abstract][Full Text] [Related]
34. Genetic polymorphism in the transforming growth factor beta1 gene (-509 C/T and -800 G/A) and colorectal cancer.
Amirghofran Z; Jalali SA; Ghaderi A; Hosseini SV
Cancer Genet Cytogenet; 2009 Apr; 190(1):21-5. PubMed ID: 19264229
[TBL] [Abstract][Full Text] [Related]
35. A C/T polymorphism in the urokinase-type plasminogen activator gene in colorectal cancer.
Przybylowska K; Smolarczyk K; Blasiak J; Kulig A; Romanowicz-Makowska H; Dziki A; Ulanska J; Pander B
J Exp Clin Cancer Res; 2001 Dec; 20(4):569-72. PubMed ID: 11876553
[TBL] [Abstract][Full Text] [Related]
36. EPHB2 germline variants in patients with colorectal cancer or hyperplastic polyposis.
Kokko A; Laiho P; Lehtonen R; Korja S; Carvajal-Carmona LG; Järvinen H; Mecklin JP; Eng C; Schleutker J; Tomlinson IP; Vahteristo P; Aaltonen LA
BMC Cancer; 2006 Jun; 6():145. PubMed ID: 16740153
[TBL] [Abstract][Full Text] [Related]
37. Prion protein (PrPc) immunocytochemistry and expression of the green fluorescent protein reporter gene under control of the bovine PrP gene promoter in the mouse brain.
Bailly Y; Haeberlé AM; Blanquet-Grossard F; Chasserot-Golaz S; Grant N; Schulze T; Bombarde G; Grassi J; Cesbron JY; Lemaire-Vieille C
J Comp Neurol; 2004 May; 473(2):244-69. PubMed ID: 15101092
[TBL] [Abstract][Full Text] [Related]
38. Resistin in human colorectal cancer: increased expression independently of resistin promoter -420C > G genotype.
Wågsater D; Mumtaz M; Lofgren S; Hugander A; Dimberg J
Cancer Invest; 2008 Dec; 26(10):1008-14. PubMed ID: 18798067
[TBL] [Abstract][Full Text] [Related]
39. Polymorphism in MHC class II transactivator gene is not associated with susceptibility to colorectal cancer in Swedish patients.
Mumtaz M; Löfgren S; Hugander A; Dimberg J
Anticancer Res; 2008; 28(3B):1789-91. PubMed ID: 18630461
[TBL] [Abstract][Full Text] [Related]
40. A single nucleotide polymorphism in the human PIGK gene associates with low PIGK expression in colorectal cancer patients.
Dasgupta S; Pal P; Mukhopadhyay ND; Fu Y; Ratovitski EA; Moon CS; Hoque MO; Fisher PB; Trink B
Int J Oncol; 2012 Oct; 41(4):1405-10. PubMed ID: 22824918
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
